gression to end stage renal failure occurs shortly after,
Setting-Outpatient clinic of Helsinki University known whether microalbuminuria has the same Hospital.
predictive value in patients with longstanding (more Subjects-72 consecutive patients who had had than 15 years) insulin dependent diabetes. This insulin dependent diabetes for over 15 years.
information is urgently needed in order to define Main outcome measures-Urinary albumin appropriate screening and follow up programmes for excretion rate, mortality, and prevalence of diabetic diabetic patients. complications after 10 years.
Results-56 patients were re-examined at 10 year Patients and methods follow up, 10 had died, five were lost to follow up, and one was excluded because of non-diabetic In 1980 we recruited from our outpatient clinic 72 kidney disease. At initial screening 22 patients had consecutive patients with longstanding (over 15 years), macroalbuminuria, 18hadmicroalbuminuria, and 26 insulin dependent diabetes who were negative for C had normal albumin excretion. Only five (28%, 950/o peptide. All had urinary albumin excretion rates confidence interval 10% to 54%) of the micro-measured (table I) . Patients were considered negative albuminuric patients developed macroalbuminuria for C peptide if peptide concentration six minutes after during the 10 year follow up and none developed end an intravenous injection of 1 mg glucagon was less than stage renal failure. Two (8%, 1% to 25%) normo-02 nmol/l. One patient was later excluded from the Fourth Department of albuminuric patients developed macroalbuminuria follow up study because of coexisting renal disease Medicine, Helsinki and four (15%, 4% to 35%) became micro-(proteinuria and haematuria were present at onset of University Hospital, albuminuric. Seven (32%, 14% to 5/5%) of the macro-diabetes). Ten patients died during the 10 year follow Glycatedhaemoglobin (%/) 9 9 (0 3; 5 8-13 3) 10 4 (0 3; 7 6-13 1)
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Plasma glucose concentration was measured with a hexokinase method (Boehringer Mannheim, Mannheim, Germany) and glycated haemoglobin by microcolumn chromatography (Isolab, Akron, Ohio, United States). 'The reference level for the haemoglobin assay was 5-7%. Plasma triglyceride and serum cholesterol concentrations were measured by commercially available methods (Boehringer Mannheim, Mannheim, Germany) and high density lipoprotein cholesterol after ultracentrifugation of plasma. Urine concentrations of albumin were determined immunoturbidimetrically.5 The sensitivity of the albumin assay was 5 mg/l and the coefficient of variation 7 5%.
All results are expressed as the mean (SE) with 95% confidence intervals. The Mann-Whitney test was used to test the equality of group means and X2 test to test the significance of frequency differences.
Results
Twenty nine of the patients examined in 1980 were normoalbuminuric and 26 were available for re-examination in 1990 (figure). By 1990 two patients (80/n; 95%/o confidence interval 1% to 25%) had developed macro- 10-2 (0-6; 8-5 to 11 -9) 9 7 (0-4; 8-8 to 10-6) Mean glycated haemoglobin (%)* 11 -1 (0-5; 9 9 to 12-3) 9-3 (0-4; 8-5 to 9-9) < 0-02 Cholesterol (mmolIA () 11 -1 (0-7; 9-3 to 12-9) 10-1 (0-5; 9-2 to 1 1-1) Mean glycated haemoglobin ("/(,)t 10-5 (0-8; 8-8 to 12-2) 9-5 (0-3; 8-8 to 10-1) Cholesterol (mmol/1) 6-6 (0-6; 5-0 to 8-2) 6-0 (0-3; 5-3 to 6 7) High density lipoprotein cholesterol (mmol/l) 1-4 (0-2; 0-8 to 2-0) 1-7 (0-2; 1-4 to 2-0) Triglyceride (mmoUl) 1 1 (0-1; 0-7 to 1-5) 1-1 (0-2; 0 7 to 1-5) Creatinine clearance (ml/s 1-73 mr) albuminuria and four (1 5%; 4% to 35%) had progressed to microalbuminuria, 20 patients still remained normoalbuminuric. Two patients died: one who remained normoalbuminuric died of malignancy and one who became microalbuminuric died of myocardial infarction. None of the normoalbuminuric patients had hypertension at the start of the study. Normoalbuminuric patients who progressed to microalbuminuria or macroalbuminuria had higher glycated haemoglobin concentrations during the follow up period (p<0 02), lower high density lipoprotein cholesterol concentration (p < 005), required a higher insulin dose (p<0-01), and had a shorter duration of diabetes (p < 0 02) than patients who remained normoalbuminuric (table II) .
In 1980 20 patients with insulin dependent diabetes were considered microalbuminuric, 18 of whom could be re-examined in 1990. Five patients (28%; 10% to 54%) had developed macroalbuminuria, six (33%; 13%/o to 59%) had remained microalbuminuric, and seven (39%; 17% to 64%) had urinary albumin excretion which varied between normal and the microalbuminuric range. One macroalbuminuric and one microalbuminuric patient had died of myocardial infarction (figure). Apart from higher body mass index (p < 002), the patients who progressed to overt nephropathy could not be clinically distinguished from those who remained microalbuminuric (table III) . None of the patients who progressed to macroalbuminuria had developed end stage renal failure.
Twenty two patients had macroalbuminuria in 1980. By 1990 seven, had developed end stage renal failure, 12 remained macroalbuminuric, while three had become microalbuminuric. Six patients died of cardiovascular disease during the follow up period (figure).
Discussion
Our results challenge the view that microalbuminuria is a strong predictor of overt diabetic nephropathy in all patients with insulin dependent diabetes. Our patients had had insulin dependent diabetes for more than 15 years. The prevalence of overt diabetic nephropathy was 3l1% after a mean duration of diabetes of 22-7 years, which is consistent with prevalence data reported from Denmark." The mortality in the proteinuric group was increased threefold compared with that in patients with normal -albumin excretion rates (27% V 7%). No increase in mortality was seen in patients with microalbuminuria (10%).
Only five of the 18 patients with microalbuminuria progressed to overt diabetic nephropathy compared with seven of eight in the study by Viberti et al3 and 12 out of 14 in the study by Mogensen and Christensen.4 Although our follow up period was slightly shorter than in these two papers, mean duration of diabetes at initial examination was much longer in our study (26 years v 10-14 years). As 22 (31 %) of our patients had already developed overt nephropathy at initial examination, the microalbuminuric patients may Outcotmze ofinsulin depenident diabetic patients with normoalbunminuria, microalbuminuria, and macroalbuminuria BMJ VOLUME 305 represent a subgroup of patients with a low risk of progression to overt nephropathy. In support of this, the incidence of overt diabetic nephropathy increases steeply 10 years after onset of insulin dependent diabetes mellitus and decreases after 30 years.' In addition, the prevalence of diabetic nephropathy clearly falls after 40 vears.'
PREDICTIVE FACT)ORS
Were there some clinical signs or symptoms to distinguish those patients who developed overt nephropathy from those who did not? In the study by Viberti et al, patients who developed overt nephropathy had a slightly longer duration of diabetes than those who did not. Among our initially normoalbuminuric patients, those who developed microalbuminuria or macroalbuminuria had a shorter duration of diabetes than those who remained normoalbuminuric, suggesting that long duration decreases rather than increases the risk of developing nephropathy in these patients. In addition, patients who developed microalbuminuria or macroalbuminuria had higher glycated haemoglobin concentrations during follow up than those who did not progress, indicating that poor glycaemic control contributed to the development of diabetic nephropathy. The patients who progressed to nephropathy also required a greater daily insulin dose and had lower high density lipoprotein cholesterol concentrations than the patients who remained normoalbuminuric. An increased insulin requirement suggests reduced insulin sensitivity, and low high density lipoprotein cholesterol concentrations have been attributed to insulin resistance." In line with the insulin resistance hypothesis, microalbuminuric patients who progressed to nephropathy had a higher body mass index than those who did not. An association between daily requirement of insulin and incidence of nephropathy has been reported.' SUMMARY In conclusion, in patients with insulin dependent diabetes mellitus of long duration microalbuminuria is no longer an important predictor of progression to overt diabetic nephropathy. The data also suggest that signs and symptoms of insulin resistance are common in patients who progress to overt nephropathy. Since the predictive value of microalbuminuria is different in patients with insulin dependent diabetes mellitus of over 15 years' duration, such patients should be excluded from trials aiming at preventing progression from microalbuminuria to overt proteinuria.
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